Home Page

Medical Advisory Board

Board of Directors

Contact Us

Company

Careers

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

Joseph Feldschuh, M.D., President and CEO

Dr. Feldschuh has been President of Daxor since 1974. He is on the staff of Montefiore Hospital and Medical Center. From 1966 to 1983, Dr. Feldschuh was Director of the Cardiac Metabolic Laboratory at Metropolitan Hospital. He has been a Clinical Associate Professor at Cornell Medical School. He performed the basic research at the College of Physicians and Surgeons (Columbia University) on the measurement and prediction of normal human blood volume. He is the co-inventor of the Blood Volume Analyzer and the inventor of the quantitative injection kit for the BVA-100. He is Board Certified in Cardiology and Internal Medicine.

Stephen Feldschuh, Chief Operating Officer

Stephen Feldschuh earned his undergraduate degree in Business Administration (BS) from Boston University in 1988. He also has his Master's degree (MBA) in Finance from Baruch College, 1997. After graduating college, he worked for Bear Stearns & Merrill Lynch as a Commodity Broker & Futures Trader. From 1992 to 1997, he joined Daxor as Operations Manager with various responsibilities including Quality Assurance of the laboratory. From mid 1997 to 1999, Mr. Feldschuh was a financial analyst doing mergers and acquisitions in the staffing industry for Headway Corporate Resources. Mr. Feldschuh then worked for Delia's Inc. as a Financial Controller until 2001 when he rejoined the Daxor Corporation as Vice President of Operations and recently named Chief Operating Officer.

David Frankel earned his Bachelors Degree (BBA) in Public Accounting from Hofstra University and is licensed as a CPA in New York. Prior to joining Daxor, David worked in the staffing industry as a Controller at Strategic Workforce Solutions and Charles River Computers and was at Winston Resources for five years, serving as Principal Financial Officer from May 1993 through August 1995. David was the Controller of Stern Stewart, a multi-office International Financial Consulting Firm from March 1997 through August 2004.

Diane Meegan joined Daxor Corporation in February 2002 as the Senior Executive Assistant to the CEO and President. Ms. Meegan is currently the Corporate Secretary. Ms. Meegan served as the Official Executive Assistant to the CEO of Newbridge Securities, a wholly owned subsidiary of Citigroup, for 13 years. For 4 years, she served as a member of their Problem Review Board. In the past 2 years, she served as the Executive Assistant to the Head of Operations at Instinet Clearing Services.

Deanna O'Brien joined Daxor in 2003. She has over 15 years of experience in laboratory medicine. She is licensed as a Clinical Laboratory Director and has accreditations as a Medical Technologist and Clinical Laboratory Scientist. Ms. O'Brien graduated first in her class in 1991 with a BS degree in Medical Technology. She also provides assessment services for the AABB. Ms. O'Brien has been a Clinical Laboratory Director for Medex Regional Laboratories and a researcher in reverse transcriptase for Aventis Pharmaceuticals. While at Medex, she also served as FDA liaison for clinical trials.

John Reyes-Guerra has over 15 years of management, marketing and sales experience in the healthcare/medical device and service industry. Reyes-Guerra has worked with industry leading companies specializing in bringing to market various services and products for BFI Medical Systems, Picker International Health Care, Stryker Medical and Toshiba America Medical Systems. John holds a Bachelor of Science in Marketing from Elmira College.

Ev Engstrom joins Daxor with over 25 years of product development and operations management experience in the medical device industry During 8 years with Beckman Coulter, Mr. Engstrom was responsible for small hematology system development, leading the development of the Ac*T series of low cost hematology analyzers. Previously he was with Bayer Diagnostics for 16 years in various positions, including project manager for the first four generations of the GLUCOMETER blood glucose monitors, manager of product engineering, and manager of manufacturing.

Gary Fischman, Ph.D., Vice President, R&D

Gary Fischman obtained his Doctor of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine and his Ph.D. in Pathology from Thomas Jefferson University. He joined Daxor in May 1998 and he comes from a background of teaching and research. He is a diplomate of the American Academy of Pain Management.